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Objective: Extubation failure is a serious complication after cardiac surgery. The role of noninvasive positive-
pressure ventilation for acute respiratory failure in patients undergoing cardiac surgery is unknown. This study
aimed to assess the safety of implementing noninvasive positive-pressure ventilation in this setting and its impact
on lung function and operative outcomes.
Methods: In a 6-month pilot prospective survey, the study population comprised 43 patients (32were male with
a mean age of 65.73 9 years; 3 heart transplantations, 18 coronary artery bypass grafts, 5 aortic dissections, and
17 valvular procedures; 34 active smokers, 25 with medically treated chronic obstructive pulmonary disease, 21
emergency/urgency procedures) who required noninvasive positive-pressure ventilation for acute respiratory fail-
ure after initial weaning from a respirator. The cause of acute respiratory failure (classified as post-cardiopulmo-
nary bypass lung injury in 48.8% [21 patients], cardiogenic edema in 30.2% [13 patients], and pneumonia in
21% [9 patients]), length of noninvasive positive-pressure ventilation support, respiratory ratios (arterial oxygen
tension/fraction of inspired oxygen assessed immediately before noninvasive positive-pressure ventilation, and
every 6 hours after institution of pressure ventilation), and need for reintubation along with a set of predefined
safety parameters were recorded.
Results: The mean length of noninvasive positive-pressure ventilation support was 33.8  24.04 hours. Plotting
respiratory ratios with length of noninvasive positive-pressure ventilation supports a significant improvement was
already evident within the first 6-hour frame (133.6  39.5 vs 205  65.7; P<.001) for all causes. Noninvasive
positive-pressure ventilation prevented intubation in 74.4% of the patients, with satisfactory recovery for post-
cardiopulmonary bypass lung injury and cardiogenic dysfunction (90.5% and 69.2%, respectively) and poor
results (55% reintubated) in those treated for pneumonia. Noninvasive positive-pressure ventilation safety
approached 97.7%.
Conclusion: In appropriate candidates, noninvasive positive-pressure ventilation exerts favorable effects on lung
function, preventing reintubation. The cost-effectiveness of its systematic use in this setting should be assessed.
Because of increasingly complex surgical candidates, extu-
bation failure after cardiac surgery is becoming a common
complication of perioperative course.1-4 Reinstitution of tra-
cheal intubation and mechanical ventilation increases the
use of intensive care unit and hospital resources and severely
affects morbidity and mortality.1,3,5 Noninvasive positive-
pressure ventilation (NPPV) has become a standard of care
in acute respiratory failure.6,7 However, little and controver-
sial data are available on its usefulness in post-extubation
failure after major surgery and in particular after cardiac pro-
cedures.8-13 Further, outcome descriptors for noninvasive
ventilation have been poorly defined.
The primary purpose of this 6-month pilot survey was to
document the safety of implementing NPPV in this setting
and its impact on lung function and operative outcomes.
Secondary end points were to investigate the role of the
underlying cause of respiratory failure as NPPV outcome
predictor.
MATERIALS AND METHODS
Patient Population
Between January and July of 2007, we enrolled 43 consecutive adult
patients who underwent cardiac surgery procedures at our tertiary referral
center and experienced hypoxemic acute respiratory failure after prior suc-
cessful weaning from ventilator support and extubation. The study was con-
ducted in accordance with the principles of the Declaration of Helsinki. The
local ethics committee approved the protocol, and written informed consent
was always obtained.
Extubation Criteria
According to current guidelines,14 after a conventional weaning proto-
col, patients were extubated when they met the following conditions: awake
and cooperative and no evidence of focal or global neurologic deficit; bleed-
ing from mediastinal and pleural drainage less than 100 mL/h; urine output
of greater than 0.5 mL/kg/h; hemodynamic stability without the need for
high dosage of vasopressors, inotropes, or intraaortic balloon pump; no se-
vere arrhythmia; respiratory rate less than 30 breaths/min, arterial oxygen
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DAbbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
FIO2 ¼ fraction of inspired oxygen
NPPV ¼ noninvasive positive-pressure ventilation
PaO2 ¼ arterial oxygen tension
tension (PaO2) greater than 70 mm Hg, with fraction of inspired oxygen
(FIO2) less than 0.35 and positive end-expiratory pressure of 5 cm H2O or
less; normocapnia, with pressure support of 10 cm H2O or less; and body
core temperature greater than 36.6C, absence of persistent or worsening
metabolic acidosis with arterial pH greater than 7.35, and bicarbonate of
greater than 20 mmol/L. Prophylactic respiratory physiotherapy was always
performed through intense physical therapy, incentive spirometry, and early
mobilization.15
Noninvasive Ventilation
As recommended by current guidelines,6 NPPV was applied when acute
respiratory distress occurred, including severe dyspnea at rest and all of the
following: respiratory rate more than 30 breaths/min; hypoxemia arterial
partial pressure of oxygen/inspired oxygen fraction ratio (PaO2/FIO2) less
than 200 while breathing oxygen through a Venturi mask; and active con-
traction of the accessory muscles of respiration or paradoxical abdominal
motion after ensuring adequate analgesia, ability to protect airway, and air-
way secretion clearance. NPPV was achieved using a flow generator with
an adjustable inspiratory oxygen fraction set to deliver a flow up to 140 L/
min and a spring-loaded expiratory pressure valve and applied using a la-
tex-free polyvinyl chloride transparent helmet.16 For all patients, NPPV
was started at 7.5 cm H2O. The level could be decreased to 5 cm H2O or
increased to 10 cm H2O as needed according to clinical response and tol-
erance. After the first hour, FIO2 was adjusted to keep a PaO2 greater than 70
mm Hg. NPPV was delivered until endotracheal intubation, death, or ful-
fillment of the following cessation criteria: PaO2/FIO2 greater than 300,
95% less than arterial oxygen saturation (SaO2) less than 100%, under
FIO2 equal or lower than of 40% or less without NPPV, and respiratory
rate less than 30 breaths/min. Occurrence of CO2 rebreathing was avoided
by delivering high fresh gas flow (never<30 L/min) to wash exhaled CO2
away from the closed volume inside the helmet.
Patients had continuous electrocardiographic and oxygen saturation
monitoring along with invasive hemodynamic monitoring. Arterial blood
gas levels were determined at baseline and at 1 and 6 hours thereafter.
Exclusion Criteria
Patients with any of the following were not included in the trial: lack of
consciousness; deformity of upper airways; acute bleeding of the upper air-
ways; severe pulmonary emphysema with bullae; hypercapnic respiratory
failure, severe sepsis; hypoxemic respiratory failure after accidental self- ex-
tubation; or pneumothorax.
Criteria for Endotracheal Intubation
Patients who failed to improve with noninvasive ventilation underwent
endotracheal intubation with cuffed endotracheal tubes and were mechani-
cally ventilated. Reintubation was performed if 1 major or 2 minor criteria
were present. Major criteria were respiratory arrest, loss of consciousness,
severe agitation, hemodynamic instability, and cardiogenic shock. Minor
criteria were respiratory rate more than 35 breaths/min and higher than ad-
mission value, arterial pH less than 7.30 and lower than admission value,
PaO2 less than 45 mm Hg despite oxygen supplementation, neurologic
deterioration, and weak cough reflex with secretion accumulation.
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The primary outcome variables were the need for endotracheal intuba-
tion, PaO2/FIO2 ratios, and hospital morbidity and mortality of NPPV. The
secondary end point was to evaluate the role of the underlying cause of
respiratory failure as a predictor on noninvasive ventilation failure. Acute
respiratory failure was classified as follows: post-cardiopulmonary bypass
(CPB) lung impairment (acute lung injury criteria without cardiogenic com-
promise and negative ‘‘pneumonia’’ criteria); pneumonia (positive microbi-
ology culture and appropriate imaging and clinical features, including
a temperature of>38.5C or<35C and white blood cell count>11 3
109 or< 4 3 109 cell/L); and cardiogenic edema (pulmonary capillary
wedge pressure>18 mm Hg, postoperative cardiac index (CI)< 1.8 L/
min/m2 and high-dosage catecholamines, intraaortic balloon pump, postop-
erative myocardial infarction, or severe arrhythmia).
Early improvement in gas exchange was defined as the ability to increase
PaO2/FIO2 more than 200 or an increase in this ratio of more than 100 from
baseline. Delayed improvement in gas exchangewas defined as the ability to
maintain the early improvement in respiratory ratios until ventilation was
discontinued, as confirmed by serial blood gas measurements. Safety pa-
rameters were as follows: skin necrosis, conjunctivitis, sinusitis, gastric dis-
tension, pneumothorax, nosocomial pneumonia, stress gastrointestinal tract
ulcer and bleeding, aspiration, cardiac arrest, and claustrophobia.
Perioperative patient variables were collected according to the standards
of the Society of Thoracic Surgeons by 3 full-time research assistants and
maintained in a computer database format.
Data Analysis
The Statistical Package for the Social Sciences software (version 10.1;
SPSS Inc, Chicago, Ill) was used for statistical analysis. Data were ex-
pressed as mean  standard deviation, or counts and percentages when
appropriate. Differences in categoric variables were compared by means
of the chi-square Pearson’s test or Fisher’s exact test. Continuous variables
were analyzed with the 2-tailed Student t test. Predictive factors for NPPV
failure were assessed in univariate and multivariable analyses on 21 vari-
ables (age, sex, diabetes, active smoking, chronic obstructive pulmonary
disease, low left ventricular ejection fraction [35%], operative procedure,
operative status, preoperative PaO2/FIO2, redo operation, CPB and aortic
crossclamp times, need and number of transfusions, surgical reexploration
for bleeding, postoperative low cardiac output, postoperative renal insuffi-
ciency, length of first intubation, interval between extubation and NPPV, in-
dication for NPPV treatment, and PaO2/FIO2 ratio<200 after first treatment
hour). The effect of the underlying cause of respiratory failure on NPPV
outcomes was evaluated by exact logistic regression model using LogXact
software to account for the small sample size (LogXact-Turbo; CYTEL
Software Corporation, Cambridge, Mass).
RESULTS
Of 465 consecutive patients who underwent operation
during the 6-month time frame of this study, post-extubation
failure developed in 44 (9.46%). Forty-three patients met
study entry criteria and constituted the NPPV group. One pa-
tient with post-extubation hypercapnic respiratory failure
and severe pulmonary emphysema with bullae was included
in the control sample. Baseline characteristics and operative
variables of study groups are summarized in Tables 1 and 2.
Patients experiencing post-extubation respiratory failure had
a significantly worse preoperative clinical status, underwent
more complex surgical procedures, and had a more demand-
ing postoperative course. The length of initial mechanical
ventilation was significantly longer in the NPPV group.
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of respiratory failure was 30.6  24.56 hours. The indica-
tions for NPPV treatment were post-CPB lung injury in
48.8% (21 patients), cardiogenic edema in 30.2% (13 pa-
tients), and pneumonia in 21% (9 patients).
Clinical Outcomes
The mean length of NPPV treatment was 33.8  24.04
hours. Figure 1 reports the pattern of respiratory ratios dur-
ing NPPV treatment. Noninvasive ventilation exerted a sig-
nificant improvement on oxygenation already evident after 1
hour of treatment. Compared with baseline, NPPV treatment
was also associated with a significant reduction in respira-
tory rate (34 [20–60] vs 28 [12–40], P< .001), a significant
increase in arterial pH levels (7.39 [7.22–7.58] vs 7.42 [7.3–
7.57], P¼ .01), and a decrease in heart rate (104 [40–150] vs
98 [60–145], P ¼ .003). Treatment compliance was 100%.
The rate of adverse events was as low as 2.3% (1 case of gas-
tric distension). Endotracheal reintubation was required
in 25.6% (11 patients). Refractory hypoxemia (36.4%)
with or without respiratory acidosis, agitation/exhaustion
(54.6%), and hemodynamic instability (9%) accounted for
endotracheal intubation. The rate of endotracheal intubation
was significantly higher in patients with underlying pneu-
monia compared with those treated for cardiogenic or CPB
lung injury (55% vs 30.8% vs 9.5%, respectively, P ¼
.03). The outcomes of patients experiencing extubation fail-
ure were poorer than those of the overall control sample.
A subsequent tracheostomy was required in 9.3%
(4 patients) in the NPPV group versus 0.94% (4 patients)
in the control group (P< .001). The lengths of intensive
care unit and hospital stay were 18.2  22.1 days and 23.6
 32 days in the NPPV group versus 2.4  4.6 and 10.9
 9.7 in the control group (P<.001), respectively. Hospital
mortality was 14% (6 patients) in the NPPV group versus
6.7% (28 patients) in the control group (P< .001). Causes
of death in the NPPV group were low cardiac output in 3
cases, multiple organ failure in 2 cases, and septic shock
in 1 case. Causes of death in controls were low cardiac out-
put in 16 cases, multiple organ failure in 5 cases, and septic
shock in 7 cases.
Outcome Predictors
Perioperative patient characteristics were evaluated as
predictors of NPPV failure. Significant univariate predictors
were PaO2/FIO2 less than 200 after the first treatment hour
(P ¼ .005), duration of initial intubation (P ¼ .01), and un-
derlying respiratory failure cause (P< .001). Multivariate
analysis revealed pneumonia (odds ratio 1.25; 95% confi-
dence interval, 1.01–6.4; P< .001) as the only independent
predictor of unsuccessful noninvasive ventilatory treatment.
DISCUSSION
This pilot prospective safety evaluation validated the im-
plementation of early NPPV in the setting of post-extubation
respiratory failure after cardiac surgery. Indeed, it relieved
hypoxemia and helped avoid reintubation in 75% of patients
who already met standard intubation criteria at study entry.
Treatment compliance was 100% with an incidence of ad-
verse events of 2.3%. The use of a helmet as NPPV interface
could explain these favorable outcomes compared with pub-
lished data.16 Cause of respiratory failure emerged as the
strongest predictor of NPPV failure in agreement with major
series.17,18 Outcome predictors are important to identify pa-
tients who are less likely to improve with noninvasive ven-
tilation, thus requiring closer observation and readily
available means of intubation. This is particularly relevant
for the patients with severe hypoxemia, in whom unneces-
sary delays in intubation may imply serious consequences.
The outcomes of NPPV treatment for post-CPB lung im-
pairment were satisfactory in the present series. Such results
TABLE 1. Perioperative features of study population
Control n ¼ 422 NPPV n ¼ 43 P
Age 62.4  12.4 65.7  9.04 .039
Sex (female) 132 (31.4%) 11 (25.6%) NS
Diabetes 89 (21.1%) 11 (25.6%) NS
Smoking 215 (51%) 34 (79.1%) .01
COPD 21 (5)% 25 (58.1%) .002
Low LVEF 44 (10.4)% 17 (39.5%) .009
Diagnosis: .02
Ischemic 201 (47. 6%) 26 (60.5%)
Valvular 164 (38.86%) 3 (7%)
Thoracic aortic 44 (10.42%) 9 (20.9%)
Transplantation 12 (2.84%) 3 (7%)
Other 1 (0.24%) 2 (4.6%)
Status .01
Elective 295 (69.9%) 22 (51.2%)
Urgent 54 (12.8%) 12 (27.9%)
Emergency 73 (17.3%) 9 (20.9%)
NPPV, Noninvasive positive-pressure ventilation; COPD, chronic obstructive pulmo-
nary disease; LVEF, left ventricular ejection fraction; NS, not significant.
TABLE 2. Perioperative features of study population
Control n ¼ 422 NPPV n ¼ 43 P
Preoperative PaO2/FIO2 381  41 357  60.4 .02
Redo 34 (8.04%) 5 (11.6%) .08
Total CPB 104.8  58.3 125.13  52.7 .001
Total aortic crossclamp 66.02  29.1 67.1  35.7 .01
Blood products 2.6  4.2 5.6  13.4 <.0001
Surgical reexploration 4 (0.94%) 2 (4.6%) <.0001
IABP 17 (4.02%) 9 (20.9%) .0004
CVVH 19 (4.5%) 10 (23.3%) .0004
Invasive monitoring 19 (4.5%) 43 (100%) <.0001
Initial MV 19.1  26.4 30.7  31.8 <.0001
NPPV, Noninvasive positive-pressure ventilation; PaO2/FIO2, arterial oxygen tension/
fraction of inspired oxygen; CPB, cardiopulmonary bypass; IABP, intraaortic balloon
pump; CVVH, continuous venovenous hemo filtration; MV, length of mechanical
ventilation (in hours).
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plained by the physiologic effects of continuous positive air-
way pressure and partly by patient stratification in this
strictly selective study.19,20
Published research has suggested that continuous positive
airway pressure and NPPV impart hemodynamic benefit in
patients with heart failure by increasing intrathoracic pres-
sure, which, in turn, reduces both cardiac preload (by imped-
ing cardiac filling) and cardiac afterload (by reducing left
ventricular transmural pressure).21,22 High-level evidence
supports the use of continuous positive airway pressure in
treating cardiogenic pulmonary edema. Pang and col-
leagues23 reported that, compared with standard therapy,
continuous positive airway pressure was associated with
less need for intubation (risk difference 26%; 95% confi-
dence interval, 13–38) and that there was a trend toward
lower hospital mortality (risk difference 6.6%; 95% confi-
dence interval, 3–16). NPPV treatment for patients with car-
diogenic pulmonary edema also proved effective in this
study. Intubation rate averaged a satisfactory 30.8%. Con-
comitant close hemodynamic monitoring, aggressive evi-
dence-based inodilator support, extensive use of intraaortic
balloon pump, and renal replacement therapy may justify
these results. Nevertheless, lower intubation rates have
been reported in published series.7,17,23 These may be ex-
plained by a different case mix and in particular by the sig-
nificant extent of preoperative cardiac impairment, the
complex comorbidity profiles, and the exclusive post-major
surgical procedure setting of present series.
The NPPV failure rate proved significantly higher in pa-
tients affected by pneumonia. In close accordance with
major series,18 strong evidence is emerging that once
satisfactory oxygenation and ventilatory assistance are at-
tained by NPPV, the major determinant of the outcome is
the response to medical therapy and the resolution of the un-
derlying disease. Pneumonia has a relatively slow onset, and
time is required for conventional medical therapy to show its
effects. Conventional endotracheal intubation still seems to
be the best intervention in this patient subset. Despite suc-
cessful NPPV treatment, mortality rates in this series are
as high as 14%, and significantly higher than those observed
0
50
100
150
200
250
300
350
400
pre-op NPPV 6 hours 12 hours 24 hours after
PaO2/FiO2
FIGURE 1. Temporal trend of PaO2/FIO2. NPPV, Noninvasive positive-
pressure ventilation; PaO2/FIO2, arterial oxygen tension/fraction of inspired
oxygen.
The Journal of Thoracic and Cin controls. Such results fit with the lower limits of reported
fatality rates and may be explained by the complex case mix
and development of multiorgan involvement.1-5
Study Limitations
Management of post-extubation failure is a highly contro-
versial issue, with a limited number of prospective random-
ized analyses partially biased by limited samples of
unselected patient populations. Despite appropriate data
analysis, the limited study sample in the present series inev-
itably hampers the inherent statistical power. Nevertheless,
the prospective setting, the uniformity of perioperative man-
agement standards inherent to a single-center analysis, and,
above all, the strict patient selection still support a definite
clinical relevance. Given the inherent limits of both endotra-
cheal reintubation and simple oxygen supplementation, this
feasibility evaluation of NPPV, added to standard intensive
care treatment, was not conducted in a randomized fashion.
Stringent exclusion and intubation criteria, drawn from evi-
dence-based guidelines, guaranteed safe and effective ‘‘state
of the art’’ patient care.
CONCLUSIONS
The present safety study shows that NPPV is a safe ad-
junct in the treatment of post-extubation failure in patients
undergoing cardiac surgery. Together with intensive stan-
dard medical management, strict patient selection is crucial
for NPPV success. Patients affected by pneumonia seem to
benefit least from this ventilatory modality. Further studies
are needed to address the proper timing and selection criteria
and to validate the cost-effectiveness of the routine imple-
mentation of this strategy.
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